Karus Therapeutics presenting at BIO, BioTrinity, Anglo-Nordic Biotech and Next-Gen Kinase Inhibitors

Oxford, UK, 19 April 2013 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, has announced that it will be making presentations at a number of key trade conferences including: BIO International Convention, Chicago, USA, 22-25th April: Simon Kerry, CEO, will present at the conference’s BIO […]

Karus Therapeutics appoints Scientific Advisory Board and announces move to new Oxford facilities

Oxford, UK, 9 April 2013 – Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, today announced the appointment of its scientific advisory board (SAB), which brings together world-leading expertise in target biology and drug research and development. The appointment of Karus’s SAB reflects the Company’s […]